XM does not provide services to residents of the United States of America.

Indian shares open higher, led by IT, pharma stocks



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares open higher, led by IT, pharma stocks</title></head><body>

Updates at 9:29 a.m. IST

BENGALURU, Sept 10 (Reuters) -Indian shares opened higher on Tuesday, led by information technology and pharma, and tracking a rebound in global stocks ahead of key U.S. inflation data and the Federal Reserve's interest rate decision.

The Nifty 50 index .NSEI was up 0.25% at 24,996.5 points, while the S&P BSE Sensex .BSESN rose 0.23% at 81,753.7, as of 9:29 a.m. IST.

"A renewed wave of dip buying has stimulated a rebound in stocks after a drop (on Monday and earlier on Tuesday),triggered by U.S. economic concerns," said Deepak Jasani, head of retail research at HDFC Securities.

Traders are now looking for U.S. inflation data for clues on the size of Fed rate cuts, said Jasani.

Wall Street equities closed higher overnight, bouncing back from a weekly drop on Friday after mixed labour market data.

The U.S. consumer price index, due on Wednesday, is expected to show that inflation remains on the path back tothe Fed's target.

The reading will be crucial to determine thesize of a likely Fedrate cut next week.

Asian markets were higher on Tuesday, though concerns over China's growth outlook capped gains. MKTS/GLOB

Barring heavyweightfinancials .NIFTYFIN, which logged marginal losses, all the other sectors advanced.

IT companies .NIFTYIT, which earn a significant share of their revenue from the U.S., gained 0.8%.

The pharmaindex .NIPHARM gained 1% after India's goods and services tax (GST) council recommended a reduction in tax rates on specific cancer drugs.

Snack makers like Gopal Snacks GOPA.NS, Prataap Snacks PRAT.NS and Bikaji Foods BIKA.NS rose about5% each after the GST council recommended cutting tax rate on "namkeen", or Indian savory snacks, to 12% from 18%.

The more domestically focussed small- .NIFSMCP100 and mid-caps .NIFMDCP100 rose about 1.1% each.




Reporting by Bharath Rajeswaran in Bengaluru; Editing by Rashmi Aich and Sonia Cheema

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.